Downbeat nystagmus due to ranitidine in a pediatric patient

Eur J Paediatr Neurol. 2017 Jul;21(4):682-684. doi: 10.1016/j.ejpn.2017.01.015. Epub 2017 Feb 11.

Abstract

Background: Ranitidine has not been considered as a potential cause of ocular movement conditions. However, it is known that the vestibular nucleus complex, that has a key role in gaze control and vestibule-ocular reflexes, receives hypothalamic histaminergic innervations. Some studies reported the effect of ranitidine blocking the excitatory responses of vestibular nuclei neurons to histamine.

Case report: We report the first case of a downbeat nystagmus secondary to ranitidine in an infant. A 3-month-old female developed a downbeat gaze after starting treatment with ranitidine for a pediatric gastroesophageal reflux disease. Microbiological test were negative and neuroblastoma evaluation was normal.

Conclusion: As ranitidine is widely prescribed in the pediatric population, clinicians should be aware of its potential to cause ocular movements disorders.

Keywords: Infant; Nystagmus; Ocular movement disorder; Ranitidine.

Publication types

  • Case Reports

MeSH terms

  • Anti-Ulcer Agents / adverse effects*
  • Female
  • Gastroesophageal Reflux / drug therapy
  • Humans
  • Infant
  • Nystagmus, Pathologic / chemically induced*
  • Ranitidine / adverse effects*

Substances

  • Anti-Ulcer Agents
  • Ranitidine